Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy
Background: Our recent studies demonstrated that both nintedanib, an FDA-approved quadruple kinase inhibitor, and gefitinib, an epidermal growth factor receptor (EGFR) inhibitor, protect against obstructive kidney disease. It remains unknown whether they have a synergistic effect. Methods: In this s...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
Karger Publishers,
2020-08-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
इंटरनेट
Connect to this object online.3rd Floor Main Library
बोधानक: |
A1234.567 |
---|---|
प्रति 1 | उपलब्ध |